Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis

IMPORTANCE: COVID-19 convalescent plasma (CCP) is a potentially beneficial treatment for COVID-19 that requires rigorous testing. OBJECTIVE: To compile individual patient data from randomized clinical trials of CCP and to monitor the data until completion or until accumulated evidence enables reliab...

Descripción completa

Detalles Bibliográficos
Autores principales: Troxel, Andrea B., Petkova, Eva, Goldfeld, Keith, Liu, Mengling, Tarpey, Thaddeus, Wu, Yinxiang, Wu, Danni, Agarwal, Anup, Avendaño-Solá, Cristina, Bainbridge, Emma, Bar, Katherine J., Devos, Timothy, Duarte, Rafael F., Gharbharan, Arvind, Hsue, Priscilla Y., Kumar, Gunjan, Luetkemeyer, Annie F., Meyfroidt, Geert, Nicola, André M., Mukherjee, Aparna, Ortigoza, Mila B., Pirofski, Liise-anne, Rijnders, Bart J. A., Rokx, Casper, Sancho-Lopez, Arantxa, Shaw, Pamela, Tebas, Pablo, Yoon, Hyun-Ah, Grudzen, Corita, Hochman, Judith, Antman, Elliott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790669/
https://www.ncbi.nlm.nih.gov/pubmed/35076699
http://dx.doi.org/10.1001/jamanetworkopen.2021.47331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790669/
https://www.ncbi.nlm.nih.gov/pubmed/35076699
http://dx.doi.org/10.1001/jamanetworkopen.2021.47331

Ejemplares similares